Daraxonrasib: New drug that solved a 40-yr pancreatic cancer puzzle & can nearly double survival rates
Orally taken medicine, being studied specifically for metastatic pancreatic cancers, targets a cell protein that has lost the ability to ‘switch off’. India arrival still some way off.